当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析 - 现金流量表

九强生物

(300406)

  

流通市值:53.21亿  总市值:73.50亿
流通股本:4.24亿   总股本:5.86亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,117,501,561.51741,040,381.5336,831,910.181,592,602,979.54
  收到的税费返还00-172,513.55
  收到其他与经营活动有关的现金15,921,929.46,941,494.775,189,089.5422,554,276.06
  经营活动现金流入小计1,133,423,490.91747,981,876.27342,020,999.721,615,329,769.15
  购买商品、接受劳务支付的现金209,008,791.75145,197,401.8367,502,608.49291,957,694
  支付给职工以及为职工支付的现金212,900,029.3155,994,633.08100,262,384.08317,791,513.75
  支付的各项税费163,596,760.14115,303,391.8646,519,357.94197,849,182.41
  支付其他与经营活动有关的现金121,343,365.7584,690,63332,230,412.45242,621,628.02
  经营活动现金流出小计706,848,946.94501,186,059.77246,514,762.961,050,220,018.18
  经营活动产生的现金流量净额426,574,543.97246,795,816.595,506,236.76565,109,750.97
二、投资活动产生的现金流量:
  收回投资收到的现金344,574,902.75228,000,00050,000,00073,000,000
  取得投资收益收到的现金15,731,478.889,872,476.61325,000571,347.27
  处置固定资产、无形资产和其他长期资产收回的现金净额57,98048,1805,70061,294
  处置子公司及其他营业单位收到的现金净额00-0
  收到的其他与投资活动有关的现金00-0
  投资活动现金流入小计360,364,361.63237,920,656.6150,330,70073,632,641.27
  购建固定资产、无形资产和其他长期资产支付的现金12,570,727.9910,474,690.789,107,025.6839,240,751.19
  投资支付的现金210,000,00080,000,000-459,711,944.67
  取得子公司及其他营业单位支付的现金00-0
  支付其他与投资活动有关的现金00-50,000,000
  投资活动现金流出小计222,570,727.9990,474,690.789,107,025.68548,952,695.86
  投资活动产生的现金流量净额137,793,633.64147,445,965.8341,223,674.32-475,320,054.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金00--
  其中:子公司吸收少数股东投资收到的现金00--
  取得借款收到的现金730,037.69580,333.9355,177.091,318,001.34
  收到其他与筹资活动有关的现金620,845.16620,845.16-6,171,412.61
  筹资活动现金流入小计1,350,882.851,201,179.06355,177.097,489,413.95
  偿还债务支付的现金703,835.93471,732.54342,967.74127,419,550.98
  分配股利、利润或偿付利息支付的现金512,769,804.09427,390,757.072,639,404540,152,925.64
  其中:子公司支付给少数股东的股利、利润2,639,4042,639,4042,639,4043,011,064
  支付其他与筹资活动有关的现金3,141,421.41,547,347.88208,312.220,730,183.69
  筹资活动现金流出小计516,615,061.42429,409,837.493,190,683.94688,302,660.31
  筹资活动产生的现金流量净额-515,264,178.57-428,208,658.43-2,835,506.85-680,813,246.36
四、汇率变动对现金及现金等价物的影响-987,322.6-412,679.54-194,057.48-389,715.5
五、现金及现金等价物净增加额48,116,676.44-34,379,555.64133,700,346.75-591,413,265.48
  加:期初现金及现金等价物余额539,645,136.36539,645,136.36539,645,136.361,131,058,401.84
  期末现金及现金等价物余额587,761,812.8505,265,580.72673,345,483.11539,645,136.36
补充资料:
  净利润-210,336,063.58-190,537,287.77
  资产减值准备-19,010,611.25-207,340,661.85
  固定资产和投资性房地产折旧-29,130,300.24-59,779,575.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,130,300.24-59,779,575.08
  无形资产摊销-6,287,650.64-10,310,634.48
  长期待摊费用摊销-222,433.45-492,048.26
  处置固定资产、无形资产和其他长期资产的损失-350,135.75-2,872,916.43
  固定资产报废损失-156,145.84-830,079.58
  公允价值变动损失---0
  财务费用-24,767,748.09-49,832,952.55
  投资损失--7,336,210.85--12,135,601.29
  递延所得税--8,792,547.62--9,671,517.68
  其中:递延所得税资产减少--8,306,702.27--8,769,308.6
    递延所得税负债增加--485,845.35--902,209.08
  存货的减少--5,977,269.86-20,902,666.99
  经营性应收项目的减少--33,176,179.27-100,069,630.45
  经营性应付项目的增加-10,861,467.58--57,577,720.62
  一年内到期的可转换公司债券---8,407,665.78
  现金的期末余额-505,265,580.72-539,645,136.36
  减:现金的期初余额-539,645,136.36-1,042,657,721.31
  减:现金等价物的期初余额---88,400,680.53
  现金及现金等价物的净增加额--34,379,555.64--591,413,265.48
公告日期2026-10-282026-08-222026-04-272026-04-27
审计意见(境内)标准无保留意见
TOP↑